中文 | English
Return
Total: 307 , 1/31
Show Home Prev Next End page: GO
MeSH:(Biomarkers, Tumor/*analysis)

1.Research advances of techniques for quantum dots-based tumor marker detection.

Wanting NIU ; Renhui WANG ; Hao YANG ; Min PAN ; Yuquan CHEN

Journal of Biomedical Engineering 2010;27(3):707-710

2.Prognostic Value of CEA and CA19 - 9 in Serum and Peritoneal Washing Fluid in Gastric Carcinoma.

Sang Uk HAN ; Yong Kwan CHO ; Seong Woo HONG ; Young Ae LIM ; Yun Sik KWAK ; Myung Wook KIM

Journal of the Korean Cancer Association 1998;30(5):869-878

3.Discussion on Current Registration Situation and Problems of in Vitro Diagnostic Device of Tumor Marker.

Zhaozhao HAN

Chinese Journal of Medical Instrumentation 2015;39(5):361-362

4.Proteomic technology for biomarker profiling in cancer: an update.

Moulay A ALAOUI-JAMALI ; Ying-jie XU

Journal of Zhejiang University. Science. B 2006;7(6):411-420

5.Prognostic significance of lymphocyte function associated anti-gen-3 (CD58) in childhood B cell-acute lymphocytic leukemia.

Chong XU ; Hui-Jun ZHAO ; Li-Ming JIANG ; Xiao-Jun YUAN ; Li LI ; Jing-Yan TANG ; Li-Song SHEN

Journal of Experimental Hematology 2006;14(4):717-721

8.Malignant gastrointestinal neuroectodermal tumor: a clinicopathological analysis of three cases.

C Y FAN ; Y X WANG ; P Z HU ; S J YANG

Chinese Journal of Pathology 2023;52(8):791-796

9.The Prognostic Significance of the Preoperative Serum CEA, CA19-9 and AFP Levels in Gastric Cancer Patients.

Kuk Young NA ; Yeon Soo CHANG ; Yong Ho KIM ; Sun Hyung JOO ; Suk Hwan LEE

Journal of the Korean Surgical Society 2008;75(5):302-306

10.Clinical utility of tumor marker cutoff ratio and a combination scoring system of preoperative carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4 levels in gastric cancer.

Jong Chan LEE ; Se Youl LEE ; Chan Young KIM ; Doo Hyun YANG

Journal of the Korean Surgical Society 2013;85(6):283-289

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 307 , 1/31 Show Home Prev Next End page: GO